Reversible benzodiazepine-receptor imaging changes after moyamoya bypass

A case linked transient neurological symptoms with altered receptor-tracer binding during cerebral hyperperfusion.

The chronological imaging finding

A 20-year-old woman developed hyperperfusion syndrome after bypass surgery for moyamoya disease. Imaging showed reduced central benzodiazepine-receptor binding potential in the affected region, alongside perfusion changes. Four months later, the imaging findings had resolved and neurological examination was normal.

The receptor measurement used a tracer technique. It was not a blood test for a consumed benzodiazepine.

Binding potential has multiple determinants

A reduced tracer signal may reflect changes in receptor availability, tissue function, or measurement conditions. One case cannot prove the complete molecular mechanism or establish how often this pattern occurs. Resolution also does not prove that every receptor-signal decrease represents reversible dysfunction.

For interpretation, distinguish receptor imaging from medication exposure and retain the surgical and perfusion timeline. The paper supports a possible reversible functional process, not a diagnostic marker of benzodiazepine intoxication or permanent neuronal loss.

Source paper

Original analysis of the supplied journal article, identified as PMC6236211.

Related research

• Benzodiazepine-Challenge Imaging Model Inferred Developmental Changes in Cortical Inhibition
• A Benzodiazepine-Positive Result After Emergency Sedation May Reflect Treatment Rather Than the Initial Overdose